ClinConnect ClinConnect Logo
Search / Trial NCT05039021

A Prospective, Single-Arm Multi-Center Study of the HARMONIC® 1100 Shears in Select Devices

Launched by ETHICON ENDO-SURGERY · Aug 31, 2021

Trial Information

Current as of July 23, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pediatric population:
  • 1. Non-emergent procedure (general) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
  • 2. Less than 18 years of age at the time of procedure; and
  • 3. The subject's parent/legal guardian must be willing to give permission for the subject to participate in the study and provide written informed consent for the subject. In addition, assent must be obtained from pediatric subjects who possess the intellectual and emotional ability to comprehend the concepts involved in the study. If the pediatric subject is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the study), the parent/legal guardian's written informed consent for the subject will be acceptable for the subject to be included in the study.
  • Adult population:
  • 1. Elective procedure (general, gynecological, urological, or thoracic) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
  • 2. Willingness to give consent and comply with all study-related evaluations and visit schedule; and
  • 3. At least 18 years of age.
  • Exclusion Criteria:
  • Preoperative
  • 1. Physical or psychological condition which would impair study participation;
  • 2. Female subjects, of childbearing age, who are pregnant; or
  • 3. Enrollment in a concurrent interventional clinical study that could impact the study endpoints.
  • Intraoperative
  • 1. The HARMONIC 1100 Shears were not attempted to be used for at least one single vessel transection during the surgical procedure.

About Ethicon Endo Surgery

Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, is a leading global innovator in surgical devices and technologies, specializing in minimally invasive surgical solutions. With a commitment to advancing patient care, the company focuses on developing cutting-edge products that enhance surgical efficiency and improve patient outcomes. Ethicon Endo-Surgery conducts rigorous clinical trials to evaluate the safety and efficacy of its innovative devices, contributing to the evolution of surgical practices across various specialties. Through collaboration with healthcare professionals and ongoing research, the company aims to set new standards in surgical performance and patient safety.

Locations

Indianapolis, Indiana, United States

Toronto, , Canada

Indianapolis, Indiana, United States

Edinburgh, Scotland, United Kingdom

Jacksonville, Florida, United States

Indianapolis, Indiana, United States

Montreal, , Canada

Patients applied

0 patients applied

Trial Officials

Ethicon Endo-Surgery Clinical Trial

Study Director

Ethicon Endo-Surgery

Troy Markel, MD

Principal Investigator

Riley Hospital for Children at Indiana University Health

Attila Nakeeb, MD

Principal Investigator

IU Health University Hospital

Moishe Liberman, MD

Principal Investigator

Centre Hospitalier de l'Universite de Montreal

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials